Medicine and Dentistry
Patient
100%
Asthma
68%
Therapeutic Procedure
54%
Eosinophilic
43%
Severe Asthma
41%
Disease
29%
Eosinophil
27%
Diagnosis
22%
Rhinovirus Infection
19%
Adult
18%
Benralizumab
17%
Symptom
16%
Primary Health Care
15%
COVID-19
12%
Biological Product
11%
Biological Therapy
10%
Clinical Trial
9%
Patient Compliance
9%
Nasal Polyp
8%
Hand-Schüller-Christian Disease
8%
Etiology
8%
Wheeze
7%
Patient with Asthma
7%
Patient Referral
7%
Granulomatosis with Polyangiitis
7%
Health
7%
Therapeutics
7%
Arm
7%
Blood
7%
Consensus
6%
Association
6%
Electronic Health Record
6%
Randomized Clinical Trial
6%
Overdiagnosis
6%
Azithromycin
6%
Aspirin Exacerbated Respiratory Disease
6%
Emotion
6%
Extracorporeal Membrane Oxygenation
6%
Randomized Controlled Trial
6%
Blood Clot Lysis
6%
Noninferiority Trial
6%
Scintigraphy
6%
Alteplase
6%
Brain Ischemia
6%
Immune Disorder
6%
Sensitization
6%
Biological Marker
5%
Phenotype
5%
Female
5%
Immunology and Microbiology
Severe Asthma
77%
Asthma Exacerbation
57%
Inflammation
31%
Eosinophil Granulocyte
29%
Eosinophil
24%
Viral Disease
20%
Lung
13%
Allergic Inflammation
12%
Interferon Type I
12%
Interferon
10%
Immunology
8%
Macrophage
8%
CCL17
7%
Immunoglobulin E
7%
Allergy
7%
Innate Lymphoid Cell
6%
Dendritic Cell
6%
Immunomodulating Drugs
6%
CCL22
6%
Peripheral Blood Mononuclear Cell
6%
Natural Killer Cell
6%
Interleukin-33
6%
